Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma

Lin Gui, Junning Cao, Dongmei Ji, Huilai Zhang, Qian Fan, Jun Zhu, Yuqin Song, Shiyu Jiang, Zhiqiang Ning, Jia Yu, Yuankai ShiChinese 2021 · DOI

Abstract

The addition of chidamide to standard CHOP chemotherapy was tolerable with promising preliminary efficacy in previously untreated PTCL patients, which supports further clinical studies with this combination regimen for the frontline treatment of PTCL.
BibTeX
@inproceedings{gui2021chidamide,
  author = {Lin Gui and Junning Cao and Dongmei Ji and Huilai Zhang and Qian Fan and Jun Zhu and Yuqin Song and Shiyu Jiang and Zhiqiang Ning and Jia Yu and Yuankai Shi},
  title = {{Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma}},
  booktitle = {Chinese},
  year = {2021},
  doi = {10.21147/j.issn.1000-9604.2021.05.08},
}

Loading related content...

Figure